Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Reason why ReShape Lifesciences Stock (RSLS) is surging
Hillstream BioPharma (HILS) small cap with big moves on news
Is the surge in G Medical Innovations Holdings (GMVD) justified
Pharvaris NV (NASDAQ: PHVS) could surge more than 20% from current…
Would Summit Therapeutics Inc (NASDQ:SMMT) resort to dilution to raise cash
Finance
Is the rally in Intelligent Bio Solutions Inc (INBS) stock sustainable…
Applied DNA Sciences Inc (APDN) could keep surging and here’s why
Aeglea Bio Therapeutics Inc (NASDAQ: AGLE) Announces EMA Marketing Authorization Validation…
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:FOLD
Tag: NASDAQ:FOLD
Amicus Therapeutics, Inc. (NASDAQ: FOLD) Gets a Patent For Migalasat
Matt Wade
-
April 25, 2022
0
Amicus Therapeutics (NASDAQ: FOLD) Receives MAA Approval From EMA For AT-GAA...
Gavins Felicity
-
December 17, 2021
0
Amicus Therapeutics, Inc. (NASDAQ: FOLD) Announces that it is Preparing to...
Gavins Felicity
-
October 12, 2021
0
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Reports Topline Results Of AT-GAA In Phase...
Ward Sport
-
February 22, 2021
0
Amicus Therapeutics (NASDAQ:FOLD) Commences Rolling BLA For AT-GAA In Treatment Of...
Gavins Felicity
-
December 11, 2020
0
Amicus Therapeutics Inc. (NASDAQ:FOLD) Reports Q3 2020 Financial Results With Galafold...
Kate Hudson
-
November 13, 2020
0
Amicus Therapeutics (NASDAQ:FOLD) Announce Encouraging Preliminary AT-GTX-501 Gene Therapy Results In...
Gavins Felicity
-
October 28, 2020
0
Amicus Therapeutics (NASDAQ:FOLD) Granted PRIME Designation By European Medicines Agency For...
Ward Sport
-
September 30, 2020
0
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Posts Revenues Of $62.4 Million In Q2...
Gavins Felicity
-
August 26, 2020
0
Recent Post
IS SPDR S&P 500 ETF (SPY) Trust heading for a breakout...
Gavins Felicity
-
February 7, 2023
0
Markets are flat in early pre-market trading today as investors have their eyes on the Fed today shortly after noon. Yesterday, we...
Reason why ReShape Lifesciences Stock (RSLS) is surging
February 3, 2023
C3.ai Inc (NYSE:AI) gains over 30% in 3 days on strength...
February 1, 2023
SOBR Safe Inc. (SOBR) storms Wall Street with over 60% gains
January 31, 2023
Atlas Technical Consultants (ATCX) surges post news of all cash deal
January 31, 2023